A new marker for the most common form of ALS

March 29, 2017

A molecule found in blood and cerebrospinal fluid could serve as an indicator for the most common form of amyotrophic lateral sclerosis (ALS), offering a much needed tool to measure disease outcomes in clinical trials, a new study reports. No effective treatments currently exist for ALS (also known as Lou Gehrig's disease), a neurodegenerative disorder that rapidly progresses from symptoms of weakness and muscle atrophy to complete paralysis and death within 30 months of the initial diagnosis in almost half of all cases. Despite more than 30 clinical trials since 1995, only one ALS treatment has been brought to market, and that compound, Riluzole, only extends survival by two to three months. Here, Tania Gendron and colleagues demonstrated that a genetic change associated with the most common form of ALS - known as C9ORF72 - also caused an abnormal protein called polyGP to accumulate in the cerebrospinal fluid (CSF) and blood cells of patients. The researchers detected polyGP in CSF from 134 individuals with the C9ORF72 form of ALS, including from 83 ALS patients, 24 people with diseases other than ALS, and 27 asymptomatic carriers. Interestingly, polyGP was not found in CSF from 120 people lacking the C9ORF72 mutation, including 57 patients with a different form of ALS. What's more, when the scientists administered a therapy targeting the C9ORF72 mutation in mouse models of C9ORF72 ALS, they observed reduced polyGP levels in the animals' CSF. The authors say that with further development, polyGP may prove to be a useful pharmacodynamic marker for therapeutic responses in clinical trials, especially for those patients who carry the mutation, but are not yet symptomatic.
-end-


American Association for the Advancement of Science

Related Amyotrophic Lateral Sclerosis Articles from Brightsurf:

Converting lateral scanning into axial focusing to speed up 3D microscopy
In optical microscopy, high-speed volumetric imaging is limited by either the slow axial scanning rate or aberrations introduced by the z-scanning mechanism.

Ammonium triggers formation of lateral roots
Despite the importance of changes in root architecture to exploit local nutrient patches, mechanisms integrating external nutrient signals into the root developmental program remain poorly understood.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Adjustable lordotic expandable vs static lateral lumbar interbody fusion devices
The objective of this study is to compare the clinical and radiographic outcomes between patients treated with static and expandable interbody spacers with adjustable lordosis for MIS LLIF.

Chirality-assisted lateral momentum transfer for bidirectional enantioselective separation
Chiral nanoparticles which twist the light were theoretically predicted to experience lateral forces perpendicular to light vector but lacks experimental verification.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

Researchers delay onset of amyotrophic lateral sclerosis (ALS) in laboratory models
Scientists have delayed the onset of amyotrophic lateral sclerosis (ALS) in laboratory models, leaving them cautiously optimistic that the result, combined with other clinical advances, points to a potential treatment for ALS in humans.

Emerging role of adenosine in brain disorders and amyotrophic lateral sclerosis
The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis (ALS).

New clues about the origins of familial forms of Amyotrophic lateral sclerosis
A Brazilian study made important progress in understanding the accumulation of one of the proteins involved in amyotrophic lateral sclerosis (ALS).

Recrutement of a lateral root developmental pathway into root nodule formation of legumes
Peas and other legumes develop spherical or cylindrical structures -- called nodules -- in their roots to establish a mutually beneficial relationship with bacteria that convert atmospheric nitrogen into a useable nutrient for the legume plant.

Read More: Amyotrophic Lateral Sclerosis News and Amyotrophic Lateral Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.